BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27421751)

  • 1. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
    Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
    Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
    Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
    Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis.
    Gupta V; McGunigal M; Prasad-Hayes M; Kalir T; Liu J
    Gynecol Oncol; 2017 Jan; 144(1):119-124. PubMed ID: 27793358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma.
    Shaikh T; Churilla TM; Mantia-Smaldone GM; Chu C; Rubin SC; Anderson PR
    Gynecol Oncol; 2016 Jun; 141(3):434-439. PubMed ID: 27090796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort.
    Wong AT; Rineer J; Schwartz D; Weiner J; Safdieh J; Choi K; Schreiber D
    Gynecol Oncol; 2017 Jan; 144(1):113-118. PubMed ID: 27823769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
    Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
    Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?
    Wang CJ; Christie A; Folkert MR; Xie XJ; Albuquerque K
    J Gynecol Oncol; 2018 Jul; 29(4):e49. PubMed ID: 29770620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma.
    Lee CM; Szabo A; Shrieve DC; Macdonald OK; Gaffney DK
    JAMA; 2006 Jan; 295(4):389-97. PubMed ID: 16434629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
    Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
    BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma Limited to the Pelvis.
    Wong AT; Lee YC; Schwartz D; Lee A; Shao M; Han P; Choi K; Schreiber D
    Int J Gynecol Cancer; 2017 Jul; 27(6):1171-1177. PubMed ID: 28574930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study.
    Albuquerque K; Folkert M; Mayadev J; Christie A; Liotta MR; Nagel C; Sevak P; Harkenrider MM; Lea JS; Hanna RK; Small WC; Miller DS; Xie XJ; Potkul RK; Elshaikh MA
    Am J Clin Oncol; 2018 Aug; 41(8):792-796. PubMed ID: 28225446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
    Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
    Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
    Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology.
    Ko EM; Brensinger CM; Cory L; Giuntoli RL; Haggerty AF; Latif NA; Aviles D; Martin L; Morgan MA; Lin LL
    Gynecol Oncol; 2020 Nov; 159(2):394-401. PubMed ID: 32800655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival.
    Boothe D; Orton A; Odei B; Stoddard G; Suneja G; Poppe MM; Werner TL; Gaffney DK
    Gynecol Oncol; 2016 Jun; 141(3):421-427. PubMed ID: 27005441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Is the Optimal Adjuvant Treatment Sequence for Node-Positive Endometrial Cancer? Results of a National Cancer Database Analysis.
    Modh A; Ghanem AI; Burmeister C; Hanna RK; Elshaikh MA
    Int J Gynecol Cancer; 2018 Feb; 28(2):248-253. PubMed ID: 29240603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center.
    Tai YJ; Hsu HC; Chiang YC; Chen YL; Chen CA; Cheng WF
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31323767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
    Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
    Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National Cancer Database.
    Nieto K; Adams W; Pham N; Block AM; Grover S; Small W; Harkenrider MM
    Gynecol Oncol; 2018 Jan; 148(1):147-153. PubMed ID: 29129389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.